MKI67 and neuroendocrine carcinoma: The 2010 WHO classification categorizes them into neuroendocrine tumor grade 1 (NET G1), neuroendocrine tumor grade 2 (NET G2) and neuroendocrine carcinoma (NEC) on the basis of the Ki-67 proliferation index and the mitotic count.